Medication info

GC Wellbeing Magnesium Chloride Injection

Prescription medicationInjections
Ingredient · strength
Magnesium Chloride›100mg / 1mL
Manufacturer / importer
GC Wellbeing Co., Ltd.
Appearance
A clear colorless liquid contained in a clear colorless ampule for injection.
Packaging
50 ampules/box[(10mL/ampule) X 50]
Approval status
Active

MFDS item code 202101707 · Notified 2021.02.19

Summary

Main use
Magnesium supplementation; treatment of hypokalemia and torsades de pointes; prevention and treatment of preeclampsia
Who uses it
Adults · Children
Adult dosage
○ Treatment of torsade de pointes - Administer magnesium 8 mmol (magnesium chloride 1.6 g) slowly as an intravenous bolus (IV Bolus). Then administer a continuous infusion of magnesium 0.012∼0.08 mmol per minute (magnesium chloride 2.5∼16.5 mg). ○ Treatment of acute hypokalemia accompanied by hypomagnesemia - Administer magnesium 24∼32 mmol (magnesium chloride 5∼6.5 g) by intravenous infusion over 24 hours each day, together with potassium supplementation. (When supplementing potassium, prepare it in a container separate from this solution.) Discontinue treatment when magnesium levels return to normal. ○ Magnesium supplementation for electrolyte imbalance and during parenteral nutrition - Administer magnesium 6∼8 mmol (magnesium chloride 1.2∼1.6 g) by intravenous infusion over 24 hours. ○ Prevention and treatment of the risk of preeclampsia (toxemia of pregnancy) - Administer slowly by intravenous injection. To treat or prevent preeclampsia, administer magnesium 16 mmol (magnesium chloride 3.25 g) by intravenous infusion over 20∼30 minutes. If preeclampsia persists, administer a further magnesium 16 mmol (magnesium chloride 3.25 g) by intravenous infusion, ensuring that the maximum cumulative amount during the first hour of treatment does not exceed magnesium 32 mmol (magnesium chloride 6.5 g). For 24 hours after the last intervention, continue intravenous infusion of magnesium 8∼12 mmol per hour (magnesium chloride 1.5∼2.0 g). ○ In adults, intravenous infusion must absolutely not exceed 120 mg per minute (0.6 mmol per minute) to avoid life-threatening hypermagnesemia.
Children's dosage
- The usual pediatric dose is magnesium 0.1∼0.3 mmol per kg (magnesium chloride 20∼60 mg) over 24 hours.

Ingredients

Manufacturer
GC Wellbeing Co., Ltd.

Efficacy & effects

Magnesium supplementation; treatment of hypokalemia and torsades de pointes; prevention and treatment of preeclampsia

  • Torsades de Pointes
  • hypomagnesemia
  • acute hypokalemia
  • electrolyte imbalance
  • pre-eclampsia
View approved original text

This medication is used to treat Torsades de Pointes, a cardiac rhythm disorder. It also helps improve hypomagnesemia associated with acute hypokalemia. It aids in maintaining normal levels through magnesium supplementation in situations of electrolyte imbalance. It provides essential minerals, such as magnesium, during parenteral nutrition, contributing to health maintenance. It is also used to prevent and treat the risk of pre-eclampsia, which is a type of pregnancy-induced hypertension. Overall, this drug improves health by balancing magnesium levels in various conditions.

Dosage and Administration

Adult dosage

○ Treatment of torsade de pointes - Administer magnesium 8 mmol (magnesium chloride 1.6 g) slowly as an intravenous bolus (IV Bolus). Then administer a continuous infusion of magnesium 0.012∼0.08 mmol per minute (magnesium chloride 2.5∼16.5 mg). ○ Treatment of acute hypokalemia accompanied by hypomagnesemia - Administer magnesium 24∼32 mmol (magnesium chloride 5∼6.5 g) by intravenous infusion over 24 hours each day, together with potassium supplementation. (When supplementing potassium, prepare it in a container separate from this solution.) Discontinue treatment when magnesium levels return to normal. ○ Magnesium supplementation for electrolyte imbalance and during parenteral nutrition - Administer magnesium 6∼8 mmol (magnesium chloride 1.2∼1.6 g) by intravenous infusion over 24 hours. ○ Prevention and treatment of the risk of preeclampsia (toxemia of pregnancy) - Administer slowly by intravenous injection. To treat or prevent preeclampsia, administer magnesium 16 mmol (magnesium chloride 3.25 g) by intravenous infusion over 20∼30 minutes. If preeclampsia persists, administer a further magnesium 16 mmol (magnesium chloride 3.25 g) by intravenous infusion, ensuring that the maximum cumulative amount during the first hour of treatment does not exceed magnesium 32 mmol (magnesium chloride 6.5 g). For 24 hours after the last intervention, continue intravenous infusion of magnesium 8∼12 mmol per hour (magnesium chloride 1.5∼2.0 g). ○ In adults, intravenous infusion must absolutely not exceed 120 mg per minute (0.6 mmol per minute) to avoid life-threatening hypermagnesemia.

Children's dosage

- The usual pediatric dose is magnesium 0.1∼0.3 mmol per kg (magnesium chloride 20∼60 mg) over 24 hours.

Precautions

When using this medication with glass ampules, there is a risk of glass fragments mixing in, so great care should be taken when cutting the container. Special caution is needed when administering to children or the elderly. The infusion rate should be adjusted slowly when administering this drug, and the patient's condition, including blood pressure, diuretic status, respiration, and reflexes, should be continuously monitored. Regularly check the magnesium levels in the blood and discontinue treatment once normal levels are reached. Co-administration with calcium-containing drugs should be avoided as it may negate the effect. This medication should not be administered to patients with impaired kidney function, severe hypotension, or cardiac and respiratory disorders. Use with special caution in children and patients with heart disease. Pain or warmth may occur at the injection site, and a rapid administration or severe kidney dysfunction may lead to dangerous magnesium overload. Combining with certain medications may cause changes in drug concentration or enhanced effects, so consulting a physician is recommended. For pregnant women, it should only be administered when necessary, as it may affect the fetus or newborn, requiring caution. During lactation, it is advisable to discontinue breastfeeding throughout the treatment period. In case of overdose, serious symptoms such as muscle paralysis, respiratory distress, and cardiac arrest may occur; appropriate treatment must be administered immediately. IV injections should be administered slowly in a professional setting with the patient stable, avoiding mixing with certain solutions as precipitation may occur.

Side effects

Pain at the injection site, vasodilation accompanied by warmth, hypermagnesemia, impaired knee reflex, warmth, drowsiness, speech impairment, muscle paralysis causing shortness of breath, respiratory arrest, cardiac arrest

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering, with a recommended storage temperature between 15 and 25 degrees Celsius. Proper storage will maintain the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

A clear colorless liquid contained in a clear colorless ampule for injection.

Package unit

50 ampules/box[(10mL/ampule) X 50]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.